Cancer Letters
Volume 220, Issue 1 , Pages 75-84, 18 March 2005

Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells

National Food Research Institute, 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8642, Japan

Received 5 May 2004; received in revised form 6 July 2004; accepted 15 July 2004.

Abstract 

Neoxanthin and fucoxanthin, which have the characteristic structure of 5,6-monoepoxide and an allenic bond, were previously found to reduce the viability of human prostate cancer cells most intensively among 15 dietary carotenoids tested. In the present study, the induction of apoptosis in PC-3 cells by these two carotenoids was characterized by morphological changes, DNA fragmentation, an increased percentage of hypodiploid cells, and cleavages of caspase-3 and PARP. The ratio of apoptotic cells reached more than 30% after treatment for 48h with 20μM carotenoids. They reduced the expression of Bax and Bcl-2 proteins, but not Bcl-XL. Fucoxanthin accumulated in the cells at the same level as neoxanthin. Moreover, fucoxanthinol, a deacetylated product of fucoxanthin, formed in the cells treated with fucoxanthin and reached a level comparable to that of fucoxanthin after incubation for 24h. Treatment by fucoxanthinol alone also induced apoptosis in PC-3 cells. Thus, neoxanthin and fucoxanthin treatments were found to induce apoptosis through caspase-3 activation in PC-3 human prostate cancer cells.

Keywords: Neoxanthin, Fucoxanthin, Fucoxanthinol, Carotenoid, Apoptosis, Prostate cancer cells

Abbreviations: DCDDF-DA, diacetoxymethyl 6-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, DMEM, Dulbecco's Modified Eagle's medium, FACS, fluorescence-activated cell sorting, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, PARP, poly (ADP-ribose) polymerase, ROS, reactive oxygen species, THF, tetrahydrofuran, TUNEL, TdT-mediated dUTP nick end labeling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(04)00635-4

doi:10.1016/j.canlet.2004.07.048

Cancer Letters
Volume 220, Issue 1 , Pages 75-84, 18 March 2005